The 20 Best Gastroesophageal Junction Cancer Doctors Near Me in Livingston, NJ

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Iron Deficiency Anemia, Large-Cell Immunoblastic Lymphoma, Childhood Iron Deficiency Anemia, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. Shah is board certified in American Board Of Internal Medicine. Dr. Shah is currently accepting new patients.

Vivek Maheshwari is a General Surgeon and a Surgical Oncologist practicing medicine in West Orange, New Jersey. Dr. Maheshwari is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Hernia, Gallstones, Choledocholithiasis, Colostomy, and Hernia Surgery. Dr. Maheshwari is currently accepting new patients.

Kevin Holzman is a Colorectal Surgeon practicing medicine in Livingston, New Jersey. Dr. Holzman is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Hemorrhoids, Rectal Prolapse, Bowel Incontinence, Ureteroscopy, and Bladder Reconstruction.

Shalini Chhabra is a Radiologist practicing medicine in Livingston, New Jersey. Dr. Chhabra is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Gastric Lymphoma, Lymphoid Hyperplasia, Lymphofollicular Hyperplasia, and Metastatic Pleural Tumor.

Debra Tarantino is a Colorectal Surgeon and a General Surgeon practicing medicine in Livingston, New Jersey. Dr. Tarantino is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Rectal Prolapse, Proctitis, Bowel Incontinence, Colostomy, and Hernia Surgery. Dr. Tarantino is board certified in American Board Of Colon And Rectal Surgery and American Board Of Surgery. Dr. Tarantino is currently accepting new patients.

Mark Gilder is a Colorectal Surgeon practicing medicine in Millburn, New Jersey. Dr. Gilder is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Proctitis, Familial Colorectal Cancer, Hemorrhoids, Hernia Surgery, and Bladder Reconstruction. Dr. Gilder is board certified in American Board Of Colon And Rectal Surgery. Dr. Gilder is currently accepting new patients.

Sonal Bordia is a Hematologist practicing medicine in Maplewood, New Jersey. Dr. Bordia is rated as an Advanced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Gastroesophageal Junction Cancer and Thrombotic Thrombocytopenic Purpura.

Usman Shah is a Hematologist and an Oncologist practicing medicine in Summit, New Jersey. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Shah is board certified in American Board Of Internal Medicine. Dr. Shah is currently accepting new patients.

Dr. Dennis Lowenthal has dedicated his career to caring for cancer patients, particularly those with lung cancer. He is the medical director of Medical Diagnostics Associates Hematology and Oncology, which is part of the Atlantic Medical Group. He also serves as medical director of Atlantic Health System’s Carol G. Simon Cancer Center at Overlook Medical Center.Growing up in the Bronx, NY, Dr. Lowenthal attended the State University of New York at Buffalo where he graduated magna cum laude with a BA in biology. He earned his medical degree at Boston University School of Medicine, continued with a medical internship at the Cleveland Clinic, and returned to the Bronx to complete his medical residency and a hematology fellowship at Montefiore Hospital and Medical Center of the Albert Einstein College of Medicine. He subsequently completed a clinical Blood Bank Directors fellowship at the New York Blood Center and then went on to complete a medical oncology fellowship at Memorial Sloan-Kettering Cancer Center where he served as Chief Fellow and Special Clinical Fellow in AIDS-related malignancies.Dr. Lowenthal considers coming to Overlook Medical Center 32 years ago one of his best life decisions, working with his colleagues to help create the Carol G. Simon Cancer Center at Overlook Medical Center. He serves as chairman of the hospital’s Cancer Committee and Cancer Center Executive Committee, and has been the long-standing section chief for Hematology/Oncology. He is co-chairman of Thoracic Oncology and the Thoracic Tumor Board at Atlantic Health System and is the principal investigator for lung cancer clinical trials conducted at Overlook Medical Center – specifically, serving as the principal investigator for the first immunotherapy approved for the treatment of lung cancer. Dr. Lowenthal is a past recipient of Overlook’s Physician Excellence in Clinical Practice award and has been an associate professor of Clinical Medicine at Columbia University College of Physicians and Surgeons, Mount Sinai School of Medicine, and currently the Sidney Kimmel Medical College at Thomas Jefferson University. Dr. Lowenthal is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Lowenthal is board certified in American Board Of Internal Medicine. Dr. Lowenthal is currently accepting new patients.

Dr. Markowski has been contributing to the field of oncology since working in a cancer research lab during and after his undergraduate work at Johns Hopkins University. A desire to care for patients brought him back to his home state of New Jersey where he completed his medical school degree at Rutgers-Robert Wood Johnson Hospital in New Brunswick, NJ. He then completed internal medicine residency and subsequent hematology/oncology fellowship training at Rutgers-Robert Wood Johnson Hospital/Cancer Institute of New Jersey.Throughout his hematology and oncology career Dr Markowski has published and presented many peer-reviewed articles, abstracts, and posters on a multitude of cancer types. He has particular interest and expertise in lung cancer, gastrointestinal cancers, and breast cancer. In addition, he has extensive experience taking care of patients with both benign and malignant blood disorders. Dr. Markowski is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Markowski is board certified in American Board Of Internal Medicine. Dr. Markowski is currently accepting new patients.

Associate Program Director of Rutgers-Robert Wood Johnson colorectal fellowship; Director of colorectal resident research; Past-President of both the New Jersey and Pennsylvania Societies of Colon and Rectal Surgeons; question writer for the American Board of Colon and Rectal Surgery written examination; Dean of ASCRS-U, invited lecturer at numerous national and international colorectal surgery meetings; author of numerous colorectal surgery book chapters; served as Chairman of numerous committees for the American Society of Colon and Rectal Surgeons (ASCRS) including the Self-Assessment Committee, Program Committee, Finance Committee, Credentials Committee, and the Nominations Advisory Task Force; President-Eugene P Salvati Alumni Association; Past-Treasurer-ASCRS, Past-Vice Chairman Surgical Leadership Institute (ASCRS); current Vice-President ASCRS; Fellow of the American College of Surgeons; Fellow of the New York Society of Colon and Rectal Surgeons; Member of the American Medical Association. Dr. Wilkins is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Proctitis, Anal Fissure, Ureteroscopy, and Hernia Surgery. Dr. Wilkins is board certified in American Board Of Colon And Rectal Surgery and American Board Of Surgery. Dr. Wilkins is currently accepting new patients.

Bertram Chinn is a Colorectal Surgeon practicing medicine in Summit, New Jersey. Dr. Chinn is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Proctitis, Lynch Syndrome, Hernia Surgery, and Colostomy. Dr. Chinn is board certified in American Board Of Colon And Rectal Surgery. Dr. Chinn is currently accepting new patients.

Suraj Alva is a Colorectal Surgeon practicing medicine in Summit, New Jersey. Dr. Alva is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Anal Fissure, Mesenteric Venous Thrombosis, Hemorrhoids, Hernia Surgery, and Ureteroscopy. Dr. Alva is board certified in American Board Of Colon And Rectal Surgery and American Board Of Surgery. Dr. Alva is currently accepting new patients.

Joseph Notaro is a Colorectal Surgeon and a General Surgeon practicing medicine in Summit, New Jersey. Dr. Notaro is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Proctitis, Familial Colorectal Cancer, Anal Fissure, Ureteroscopy, and Hernia Surgery. Dr. Notaro is board certified in American Board Of Colon And Rectal Surgery and American Board Of Surgery. Dr. Notaro is currently accepting new patients.

Rolando Rolandelli is a Colorectal Surgeon and a General Surgeon practicing medicine in Morristown, New Jersey. Dr. Rolandelli is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Diverticular Disease, Hemorrhoids, Familial Colorectal Cancer, Ileostomy, and Ureteroscopy. Dr. Rolandelli is board certified in American Board Of Surgery. Dr. Rolandelli is currently accepting new patients.

Daniel Hunt, MD, FACS, FASCRS, is a highly experienced colon and rectal surgeon with Atlantic Medical Group (AMG) offering over 15 years of expertise in the diagnosis and treatment of lower digestive tract diseases. Board-certified by the American Board of Colon & Rectal Surgery, Dr. Hunt specializes in minimally invasive surgical techniques, including advanced laparoscopic and robotic-assisted procedures for conditions such as colon cancer, diverticulitis, Crohn’s disease, ulcerative colitis, and a wide range of anorectal disorders.He is skilled in performing colonoscopies and surgical treatments for hemorrhoids, anal fistulas, and other colorectal conditions, and is deeply committed to delivering compassionate, individualized care and empowering his patients through education about their health and treatment options.Dr. Hunt earned his Bachelor of Science in Chemistry from the State University of New York at Albany and his medical degree from Mount Sinai School of Medicine in New York City. He completed his general surgery residency at SUNY Downstate Medical Center and St. Barnabas Medical Center. Following residency, he pursued specialized training in colorectal surgery through a minimally invasive colorectal fellowship at Lankenau Medical Center in Pennsylvania and a colorectal residency at New York- Presbyterian Hospital (Cornell and Columbia campuses).Prior to joining AMG, Dr. Hunt served as an assistant professor of surgery at Weill Cornell Medical College and was the site chief of colon and rectal surgery at New York-Presbyterian Hospital Lower Manhattan. He is a fellow of both the American College of Surgeons (FACS) and the American Society of Colon and Rectal Surgeons (FASCRS), and he has contributed extensively to the academic community through peer-reviewed publications and national presentations. Dr. Hunt is also a participating provider of the Atlantic Accountable Care Organization. Dr. Hunt is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. His clinical expertise encompasses Familial Colorectal Cancer, Lynch Syndrome, Colorectal Cancer, Colostomy, and Hemorrhoidectomy. Dr. Hunt is currently accepting new patients.

Dr. Bonni Lee Guerin is a hematologist/oncologist and director of the Breast Cancer Treatment and Prevention Program at Overlook Medical Center, Summit, NJ where she also serves as chair of the Breast Panel, the Multidisciplinary Breast Tumor Board and director of Oncology Education. She is the principal investigator of numerous clinical trials exploring new ways to incorporate the latest advances in the management of breast cancer. She is also actively involved in the delivery of highly-specialized immunotherapy, IL-2, for the treatment of melanoma and kidney cancer.As a medical oncologist with more than 20 years of experience, Dr. Guerin is dedicated to providing the most up to date, cutting edge treatment while looking at each of her patients as an individual. Her philosophy is one of collaboration, working with all members of the care team to provide the best outcome possible. Dr. Guerin believes that compassion and being a good listener, traits she learned from her mother, help tailor a treatment plan that reflects not only the highest order of medical care, but also one that uniquely reflects each and every patient. Dr. Guerin believes it is just as much about living well as it is living long.Dr. Guerin earned her M.D. at SUNY Stonybrook in 1988, continued her residency at Vanderbilt University in Nashville and completed her fellowship in oncology/hematology at University of California San Diego Cancer Center. She is board certified in clinical oncology and internal medicine.Since 2002, Dr. Guerin has served as chair of the Women’s Oncology Forum, Network for Oncology Communication and Research (NOCR) – a national organization. She is a diplomate of the American Society of Clinical Oncology (ASCO) and is a recipient of the Pfizer Award for Excellence in Biochemical Research and a Member of the Expert Panel Consensus Guidelines for Systemic Therapy of Metastatic Renal Cell Carcinoma. She has been named by Castle Connelly as one of NY/Metro Top Doctors for the last 10 years, as well as a Top Doctor for Women's Health. She has recently been honored by Curemonos, a New Jersey non-profit organization dedicated to supporting medically underserved women with breast cancer, and was the keynote speaker at the American Cancer Society Relay for Life in Chatham, NJ. Her interests are in breast cancer, hepatobiliary cancer and immunotherapy. Dr. Guerin is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Guerin is board certified in American Board Of Internal Medicine. Dr. Guerin is currently accepting new patients.

"Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the phase 1 Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involve active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology.Recently, she published in Lancet Oncology the results of a Phase I clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials.Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients.Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the ""Danny Danielson Translational Innovation Award"" by Hoosier Cancer Research Network for her commitment to clinical research. Dr. Alistar received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.". Dr. Alistar is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer. Dr. Alistar is board certified in American Board Of Internal Medicine. Dr. Alistar is currently accepting new patients.

Dr. Kai Bickenbach provides cancer patients with exceptional surgical care at Atlantic Surgical Oncology. His areas of specialty include melanoma, sarcoma, pancreatic cancer, liver and biliary cancer, esophageal and gastric cancer and colorectal cancer. He is trained in the use of many novel therapies, including the NanoKnife® to treat un-resectable pancreatic and liver tumors, as well as hepatic arterial infusion pumps. Dr. Bickenbach and his partners are fellowship trained surgical oncologists providing patients the latest in surgical innovation and clinical research options. Atlantic Surgical Oncology Associates work closely with medical oncology, radiation oncology and other specialists in a multidisciplinary fashion on two campuses of the Carol G. Simon Cancer Center at Morristown Medical Center and Overlook Medical Center in Summit. Dr. Bickenbach is a member of a variety of medical organizations including the American College of Surgeons, the Society of Surgical Oncology, the American Society of Clinical Oncology, and the Americas Hepato-Pancreatico-Biliary Association, and is a councilman for the New Jersey Chapter of the American College of Surgeons. He is widely published and has presented at national meetings on cancer related topics.After graduating from Wayne State University School of Medicine in 2002, Dr. Bickenbach completed his surgical residency at the University of Chicago Medical Center in 2009, where he was elected administrative chief resident. During that time, Dr. Bickenbach completed a two-year research fellowship, focusing on the use of oncolytic viruses in the treatment of cancer. Following residency, Dr. Bickenbach completed a fellowship in Surgical Oncology at Memorial Sloan-Kettering Cancer Center. He sees patients at Morristown, Overlook, Newton, Chilton and Hackettstown medical centers. He is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization. Dr. Bickenbach is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Small Bowel Resection, and Pancreatectomy. Dr. Bickenbach is board certified in American Board Of Surgery. Dr. Bickenbach is currently accepting new patients.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Experienced provider by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Philadelphia-Negative Chronic Myeloid Leukemia, Chronic Myelogenous Leukemia (CML), Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration. Dr. Scola is board certified in American Board Of Internal Medicine. Dr. Scola is currently accepting new patients.